Wednesday, 29 November 2017

Hep-C, Cancer and Hemophilia drugs to cost less as regulator caps prices of 51 formulations

  1. Hep-C, Cancer and Hemophilia drugs to cost less as regulator caps prices of 51 formulations  Moneycontrol.comFull coverage
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)